<VariationArchive VariationID="1333337" VariationName="NM_004484.4(GPC3):c.271del (p.Gln91fs)" VariationType="Deletion" Accession="VCV001333337" Version="4" RecordType="classified" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2024-06-10" DateCreated="2022-01-15" MostRecentSubmission="2024-02-20">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1324112" VariationID="1333337">
      <GeneList>
        <Gene Symbol="GPC3" FullName="glypican 3" GeneID="2719" HGNC_ID="HGNC:4451" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>Xq26.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="133535745" stop="133985594" display_start="133535745" display_stop="133985594" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="132669772" stop="133119672" display_start="132669772" display_stop="133119672" Strand="-" />
          </Location>
          <OMIM>300037</OMIM>
          <Haploinsufficiency last_evaluated="2021-01-27" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=GPC3">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2021-01-27" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=GPC3">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_004484.4(GPC3):c.271del (p.Gln91fs)</Name>
      <CanonicalSPDI>NC_000023.11:133953115:G:</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>Xq26.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="133953116" stop="133953116" display_start="133953116" display_stop="133953116" variantLength="1" positionVCF="133953115" referenceAlleleVCF="TG" alternateAlleleVCF="T" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="133087143" stop="133087143" display_start="133087143" display_stop="133087143" variantLength="1" positionVCF="133087142" referenceAlleleVCF="TG" alternateAlleleVCF="T" />
      </Location>
      <ProteinChange>Q91fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000023.10" sequenceAccession="NC_000023" sequenceVersion="10" change="g.133087143del" Assembly="GRCh37">
            <Expression>NC_000023.10:g.133087143del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000023.11" sequenceAccession="NC_000023" sequenceVersion="11" change="g.133953116del" Assembly="GRCh38">
            <Expression>NC_000023.11:g.133953116del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_009286.1" sequenceAccession="NG_009286" sequenceVersion="1" change="g.37524del">
            <Expression>NG_009286.1:g.37524del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001164617.2" sequenceAccession="NM_001164617" sequenceVersion="2" change="c.271del">
            <Expression>NM_001164617.2:c.271del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001158089.1" sequenceAccession="NP_001158089" sequenceVersion="1" change="p.Gln91fs">
            <Expression>NP_001158089.1:p.Gln91fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001164618.2" sequenceAccession="NM_001164618" sequenceVersion="2" change="c.271del">
            <Expression>NM_001164618.2:c.271del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001158090.1" sequenceAccession="NP_001158090" sequenceVersion="1" change="p.Gln91fs">
            <Expression>NP_001158090.1:p.Gln91fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_004484.4" sequenceAccession="NM_004484" sequenceVersion="4" change="c.271del" MANESelect="true">
            <Expression>NM_004484.4:c.271del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_004475.1" sequenceAccession="NP_004475" sequenceVersion="1" change="p.Gln91fs">
            <Expression>NP_004475.1:p.Gln91fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001164619.2" sequenceAccession="NM_001164619" sequenceVersion="2" change="c.175+32159del">
            <Expression>NM_001164619.2:c.175+32159del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001627" Type="intron variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_505" sequenceAccession="LRG_505">
            <Expression>LRG_505:g.37524del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="2124634791" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_004484.4(GPC3):c.271del (p.Gln91fs) AND Simpson-Golabi-Behmel syndrome type 1" Accession="RCV001808025" Version="1">
        <ClassifiedConditionList TraitSetID="3185">
          <ClassifiedCondition DB="MedGen" ID="C0796154">Simpson-Golabi-Behmel syndrome type 1</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-01-03" SubmissionCount="1">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_004484.4(GPC3):c.271del (p.Gln91fs) AND Wilms tumor 1" Accession="RCV002541464" Version="2">
        <ClassifiedConditionList TraitSetID="904">
          <ClassifiedCondition DB="MedGen" ID="CN033288">Wilms tumor 1</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-07-13" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2022-07-13" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2022-01-15" MostRecentSubmission="2024-02-20">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic/Likely pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">10402475</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">12713262</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">17603795</ID>
        </Citation>
        <DescriptionHistory Dated="2023-02-02">
          <Description>Likely pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="904" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="4506" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Wilms tumor, somatic</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Wilms tumor 1</ElementValue>
                <XRef ID="MONDO:0008679" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">WT1</ElementValue>
                <XRef Type="MIM" ID="194070" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">PAX6-related aniridia occurs either as an isolated ocular abnormality or as part of the Wilms tumor-aniridia-genital anomalies-retardation (WAGR) syndrome. Aniridia is a pan ocular disorder affecting the cornea, iris, intraocular pressure (resulting in glaucoma), lens (cataract and lens subluxation), fovea (foveal hypoplasia), and optic nerve (optic nerve coloboma and hypoplasia). Individuals with aniridia characteristically show nystagmus and impaired visual acuity (usually 20/100 - 20/200); however, milder forms of aniridia with subtle iris architecture changes, good vision, and normal foveal structure do occur. Other ocular involvement may include strabismus and occasionally microphthalmia. Although the severity of aniridia can vary between and within families, little variability is usually observed in the two eyes of an affected individual. WAGR syndrome. The risk for Wilms tumor is 42.5%-77%; of those who develop Wilms tumor, 90% do so by age four years and 98% by age seven years. Genital anomalies in males can include cryptorchidism and hypospadias (sometimes resulting in ambiguous genitalia), urethral strictures, ureteric abnormalities, and gonadoblastoma. While females typically have normal external genitalia, they may have uterine abnormalities and streak ovaries. Intellectual disability (defined as IQ &lt;74) is observed in 70%; behavioral abnormalities include attention-deficit/hyperactivity disorder (ADHD), autism spectrum disorder, anxiety, depression, and obsessive-compulsive disorder. Other individuals with WAGR syndrome can have normal intellect without behavioral problems.</Attribute>
                <XRef ID="NBK1360" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="15124" />
                <XRef ID="15124" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301471</ID>
                <ID Source="BookShelf">NBK1294</ID>
              </Citation>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301534</ID>
                <ID Source="BookShelf">NBK1360</ID>
              </Citation>
              <Citation Type="general" Abbrev="NSGC, 2004">
                <ID Source="PubMed">15604628</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2013">
                <ID Source="PubMed">23788249</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2015">
                <ID Source="PubMed">25356965</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2016">
                <ID Source="PubMed">27854360</ID>
                <ID Source="DOI">10.1038/gim.2016.190</ID>
              </Citation>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">32352694</ID>
                <ID Source="BookShelf">NBK556455</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG SF v3.0, 2021">
                <ID Source="PubMed">34012068</ID>
                <ID Source="DOI">10.1038/s41436-021-01172-3</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG SF v3.1, 2022">
                <ID Source="PubMed">35802134</ID>
                <ID Source="DOI">10.1016/j.gim.2022.04.006</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="NCCN, 2023">
                <URL>https://www.nccn.org/professionals/physician_gls/pdf/wilms_tumor.pdf</URL>
                <CitationText>NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®), Wilms Tumor (Nephroblastoma), 2023</CitationText>
              </Citation>
              <XRef ID="654" DB="Orphanet" />
              <XRef ID="CN033288" DB="MedGen" />
              <XRef ID="MONDO:0008679" DB="MONDO" />
              <XRef Type="MIM" ID="194070" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="3185" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="5916" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Simpson-Golabi-Behmel syndrome type 1</ElementValue>
                <XRef ID="MONDO:0020602" DB="MONDO" />
                <XRef ID="C118787" DB="NCI" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Simpson dysmorphia syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Bulldog syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Golabi-Rosen syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Dysplasia gigantism syndrome, X-linked</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">SGBS1</ElementValue>
                <XRef Type="MIM" ID="312870" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">DGSX</ElementValue>
                <XRef Type="MIM" ID="312870" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">SDYS</ElementValue>
                <XRef Type="MIM" ID="312870" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Simpson-Golabi-Behmel syndrome type 1 (SGBS1) is characterized by pre- and postnatal macrosomia; distinctive craniofacial features (including macrocephaly, coarse facial features, macrostomia, macroglossia, and palatal abnormalities); and commonly, mild-to-severe intellectual disability with or without structural brain anomalies. Other variable findings include supernumerary nipples, diastasis recti / umbilical hernia, congenital heart defects, diaphragmatic hernia, genitourinary defects, and gastrointestinal anomalies. Skeletal anomalies can include vertebral fusion, scoliosis, rib anomalies, and congenital hip dislocation. Hand anomalies can include large hands and postaxial polydactyly. Affected individuals are at increased risk for embryonal tumors including Wilms tumor, hepatoblastoma, adrenal neuroblastoma, gonadoblastoma, hepatocellular carcinoma, and medulloblastoma.</Attribute>
                <XRef ID="NBK1219" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301398</ID>
                <ID Source="BookShelf">NBK1219</ID>
              </Citation>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301471</ID>
                <ID Source="BookShelf">NBK1294</ID>
              </Citation>
              <XRef ID="373" DB="Orphanet" />
              <XRef ID="C0796154" DB="MedGen" />
              <XRef ID="MONDO:0020602" DB="MONDO" />
              <XRef Type="MIM" ID="312870" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="4032030" SubmissionDate="2022-01-11" DateLastUpdated="2022-01-15" DateCreated="2022-01-15">
        <ClinVarSubmissionID localKey="X-133087142-TG-T" localKeyIsSubmitted="1" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002058397" DateUpdated="2022-01-15" DateCreated="2022-01-15" Type="SCV" Version="1" SubmitterName="3billion" OrgID="507830" OrganizationCategory="other" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-01-03">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
          <Comment>Frameshift: predicted to result in a loss or disruption of normal protein function through nonsense-mediated decay (NMD) or protein truncation. Multiple pathogenic variants are reported downstream of the variant (PVS1_VS). It is not observed in the gnomAD v2.1.1 dataset (PM2_M). Therefore, this variant is classified as likely pathogenic according to the recommendation of ACMG/AMP guideline.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
              <NumberTested>1</NumberTested>
              <Proband>yes</Proband>
            </Sample>
            <Method>
              <NamePlatform>NovaSeq</NamePlatform>
              <TypePlatform>whole exome sequencing</TypePlatform>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Hemizygote" integerValue="1" />
            </ObservedData>
            <TraitSet Type="Finding">
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <XRef DB="HP" ID="HP:0000122" />
              </Trait>
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <XRef DB="HP" ID="HP:0001631" />
              </Trait>
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <XRef DB="HP" ID="HP:0000369" />
              </Trait>
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <XRef DB="HP" ID="HP:0011682" />
              </Trait>
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <XRef DB="HP" ID="HP:0000316" />
              </Trait>
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <XRef DB="HP" ID="HP:0001643" />
              </Trait>
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <XRef DB="HP" ID="HP:0002119" />
              </Trait>
            </TraitSet>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="GPC3" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_004484.4:c.271del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="312870" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB10918354</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="6022831" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-20" DateCreated="2023-02-07">
        <ClinVarSubmissionID localKey="16221425|MedGen:CN033288" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV003333158" DateUpdated="2024-02-20" DateCreated="2023-02-07" Type="SCV" Version="2" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-07-13">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">10402475</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">12713262</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">17603795</ID>
          </Citation>
          <Comment>ClinVar contains an entry for this variant (Variation ID: 1333337). For these reasons, this variant has been classified as Pathogenic. This variant has not been reported in the literature in individuals affected with GPC3-related conditions. This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Gln91Serfs*13) in the GPC3 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in GPC3 are known to be pathogenic (PMID: 10402475, 12713262, 17603795).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="GPC3" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000023.10:g.133087143del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN033288" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12507860</SubmissionName>
          <SubmissionName>SUB14200279</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="4032030" TraitType="Finding" MappingType="XRef" MappingValue="HP:0001631" MappingRef="HP">
        <MedGen CUI="C0018817" Name="Atrial septal defect" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="6022831" TraitType="Disease" MappingType="XRef" MappingValue="CN033288" MappingRef="MedGen">
        <MedGen CUI="CN033288" Name="Wilms tumor 1" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4032030" TraitType="Finding" MappingType="XRef" MappingValue="HP:0011682" MappingRef="HP">
        <MedGen CUI="C0344925" Name="Perimembranous ventricular septal defect" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4032030" TraitType="Finding" MappingType="XRef" MappingValue="HP:0000369" MappingRef="HP">
        <MedGen CUI="C0239234" Name="Low-set ears" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4032030" TraitType="Finding" MappingType="XRef" MappingValue="HP:0002119" MappingRef="HP">
        <MedGen CUI="C3278923" Name="Ventriculomegaly" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4032030" TraitType="Finding" MappingType="XRef" MappingValue="HP:0001643" MappingRef="HP">
        <MedGen CUI="C0013274" Name="Patent ductus arteriosus" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4032030" TraitType="Finding" MappingType="XRef" MappingValue="HP:0000122" MappingRef="HP">
        <MedGen CUI="C0266294" Name="Unilateral renal agenesis" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4032030" TraitType="Finding" MappingType="XRef" MappingValue="HP:0000316" MappingRef="HP">
        <MedGen CUI="C0020534" Name="Hypertelorism" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4032030" TraitType="Disease" MappingType="XRef" MappingValue="312870" MappingRef="OMIM">
        <MedGen CUI="C0796154" Name="Simpson-Golabi-Behmel syndrome type 1" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

